Clinical Trials
Study Title:
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B Acute Lymphoblastic Leukemia (B ALL)
|
For more information about the trial above please contact the study team:
|